NCT00056290View on ClinicalTrials.gov

VEGF Gene Transfer for Diabetic Neuropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Diabetic Neuropathy
Interventions
BIOLOGICAL

VEGF

3 sets of injections, at 2 week intervals

BIOLOGICAL

VEGF

3 sets of injections, at 2 week intervals

Trial Locations (2)

10032

Columbia University Neuropathy Research Center, Neurological Institute, New York

02135

Caritas St. Elizabeth's Medical Center Cardiovascular Research/DVM-4-SMC, Boston

All Listed Sponsors
lead

Losordo, Douglas, M.D.

INDIV

NCT00056290 - VEGF Gene Transfer for Diabetic Neuropathy | Biotech Hunter | Biotech Hunter